Analysts consider Ebos’ result a solid one

Analysts consider Ebos’ result a solid one
Jarden analysts have upgraded their rating for Ebos. (Image: Getty)
Ella Somers
Analysts feel upbeat but cautious about the future after healthcare wholesaler Ebos posted a better-than-expected full-year result on Wednesday.Jarden analysts Adrian Allbon and Nick Yeo upgraded their rating from underweight to neutral for the company.“Underlying cashflows were stronger than expected, with a beat on final dividend and lower net debt versus our expectations,” they wrote.Jarden's other highlights for the company included the LifeHealthcare acquisition performing “in line” with management expectations...

More Markets

NZ sharemarket claws back to end the week up 0.5%
Markets Market close

NZ sharemarket claws back to end the week up 0.5%

Index rumours drive prices on two shares. 

Graham Skellern 13 Dec 2024
Staff leave Meridian after retail 'reset'
Markets

Staff leave Meridian after retail 'reset'

Expect a very different approach from Meridian in 2025, executive says.

John Anthony 13 Dec 2024
NZX, NZSA want level playing field in climate reporting
Markets

NZX, NZSA want level playing field in climate reporting

Climate reporting liabilities for company directors could soon be eased.

Greg Hurrell 13 Dec 2024
Cannasouth delisting keeps Petterson in charge
Markets

Cannasouth delisting keeps Petterson in charge

Cannasouth major shareholders pushed to end voluntary administration they had called in.

Garth Bray 13 Dec 2024